ACHIEVE LIFE SCIENCES, INC. 4

Jeffrey S. Farrow received a grant of 25,000 stock options at $6.18 and 16,700 RSUs of Achieve Life Sciences, Inc. common stock as equity compensation.

On July 27, 2026, insider Jeffrey S. Farrow of Achieve Life Sciences, Inc. received equity-based compensation consisting of a stock option grant for 25,000 shares of common stock at an exercise price of $6.18 per share and a restricted stock unit (RSU) award covering 16,700 shares of common stock, both structured to vest 100% on the earlier of July 27, 2027 or immediately prior to the company’s 2027 annual meeting of stockholders, contingent on continued service; following these awards, Farrow holds 25,000 option rights and 16,700 RSUs, reflecting a routine compensation-related increase in his beneficial ownership position.

Filing Facts

CIK

949858

Ticker

ACHV

Form

4

Source Type

fda

Accession

0001193125-26-324238

Alert Tier

5